Are too many Australians with DCIS having sentinel node biopsy?
Surgical data suggest more than a third of women with the condition are having the procedure
Patterns of surgery for ductal carcinoma in situ have remained stable over a decade, but an increase in the use of sentinel node biopsy raises the spectre of overtreatment, researchers say.
During 2007-2016, more than a third of Australian and New Zealand women with ductal carcinoma in situ (DCIS) had sentinel node biopsy (SNB), according to figures from the BreastSurgANZ Quality Audit.
